Ottawa doctors' high-risk MS treatment yields 'impressive' results, Lancet finds
13-year trial 'first treatment to produce this level of disease control, neurological recovery,' journal finds.
http://ift.tt/25Q49HK
Possibly, just possibly, they are on to something.
At Lancet:
Science marches on. :cool:
13-year trial 'first treatment to produce this level of disease control, neurological recovery,' journal finds.
http://ift.tt/25Q49HK
Possibly, just possibly, they are on to something.
At Lancet:
Quote:
|
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial |
via International Skeptics Forum http://ift.tt/1ZCInDG
Aucun commentaire:
Enregistrer un commentaire